Cor Vasa 2022, 64(3):328-330 | DOI: 10.33678/cor.2021.125

(Application of hemoconcentration and plasma volume estimation indicators in the evaluation of the degree of congestion in a patient with heart failure)

Tereza ©»astná
Komplexní kardiovaskulární centrum, Nemocnice Na Homolce, Praha

Volume overload is still one of the most important problems associated with chronic heart failure and it is a significant prognostic factor. Monitoring of diuretic therapy by using hemoconcentration indicators and plasma volume estimation can help us increase the effectiveness of a treatment and improve drug dose titration in the context of the patient's clinical condition. In this article we would like to present a 75-year-old patient with heart failure with a preserved ejection fraction and demonstrate on her example how to use a few simple equations to estimate plasma volume and its changes.

Keywords: Duarte equation, Hakim equation, Heart failure, Hemoconcentration indicators, Kaplan equation, Plasma volume estimation, Strauss equation

Received: October 2, 2021; Revised: October 6, 2021; Accepted: November 10, 2021; Published: June 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©»astná T. (Application of hemoconcentration and plasma volume estimation indicators in the evaluation of the degree of congestion in a patient with heart failure). Cor Vasa. 2022;64(3):328-330. doi: 10.33678/cor.2021.125.
Download citation

References

  1. Vaduganathan M, Greene SJ, Fonarow GC, et al. Hemoconcentration-guided diuresis in heart failure. Am J Med 2014;127:1154-1159. Go to original source... Go to PubMed...
  2. Testani JM, Brisco MA, Chen J, et al. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 2013;62:516-524. Go to original source... Go to PubMed...
  3. Kawai T, Nakatani D, Yamada T, et al. Role of diuretics on long-term mortality may differ in volume status in patients with acute myocardial infarction. Eur Heart J 2020;41(Suppl. 2). doi:10.1093/ehjci/ehaa946.1598 Go to original source...
  4. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure. Systematic review and meta- -analysis. J Am Coll Cardiol 2006;47:1987-1996. Go to original source... Go to PubMed...
  5. Hillege HL, Nitsch D, Pfeffer , et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-678. Go to original source... Go to PubMed...
  6. Kobayashi M, Girerd N, Duarte K, et al. Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction. Clin Res Cardiol 2020;109:1392-1401. Go to original source... Go to PubMed...
  7. Ahmed A, Young JB, Love TE, et al. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol 2008;125:246-253. Go to original source... Go to PubMed...
  8. Oren RM. Hyponatremia in Congestive Heart Failure. Am J Cardiol 2005;95:2-7. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.